BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10483277)

  • 1. [Palliative accelerated irradiation for advanced non-small-cell lung bronchial carcinoma: results of a pilot study].
    Nestle U; Nieder C; Walter K; Niewald M; Motaref B; Braun-Fischer A; Ukena D; Sybrecht GW; Schnabel K
    Pneumologie; 1999 Aug; 53(8):385-92. PubMed ID: 10483277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study.
    Nestle U; Nieder C; Walter K; Abel U; Ukena D; Sybrecht GW; Schnabel K
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):95-103. PubMed ID: 10924977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC).
    Nestle U; Nieder C; Abel U; Niewald M; Ukena D; Berberich W; Schnabel K
    Radiother Oncol; 1996 Mar; 38(3):195-203. PubMed ID: 8693099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer versus conventionally fractionated 60 Gy: results of a randomized equivalence study].
    Zagamé L; Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):199. PubMed ID: 11355587
    [No Abstract]   [Full Text] [Related]  

  • 7. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC).
    Baumann M; Herrmann T; Koch R; Matthiessen W; Appold S; Wahlers B; Kepka L; Marschke G; Feltl D; Fietkau R; Budach V; Dunst J; Dziadziuszko R; Krause M; Zips D;
    Radiother Oncol; 2011 Jul; 100(1):76-85. PubMed ID: 21757247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
    Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
    J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
    Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of irradiation of inoperable stage III non-small cell lung cancer with 25Gy in five fractions].
    Appold S; Baumann M; Neidt F; Herrmann T
    Strahlenther Onkol; 1999 Jun; 175(6):267-70. PubMed ID: 10392167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
    Chmielewska E; Jodkiewicz Z; Karwański M
    Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
    Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status.
    Walasek T; Sas-Korczyńska B; Dąbrowski T; Reinfuss M; Jakubowicz J; Blecharz P; Łuczyńska E; Darasz Z; Skotnicki P
    Lung Cancer; 2015 Feb; 87(2):130-5. PubMed ID: 25484031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.
    Westover KD; Loo BW; Gerber DE; Iyengar P; Choy H; Diehn M; Hughes R; Schiller J; Dowell J; Wardak Z; Sher D; Christie A; Xie XJ; Corona I; Sharma A; Wadsworth ME; Timmerman R
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):72-81. PubMed ID: 26279026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group.
    Nyman J; Friesland S; Hallqvist A; Seke M; Bergström S; Thaning L; Lödén B; Sederholm C; Wagenius G
    Lung Cancer; 2009 Jul; 65(1):62-7. PubMed ID: 19081652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.